Gabapentin 200mg + Nortriptyline 10mg Tablet Franchise in Ahmedabad

Neuropathic Pain Medicine Supplier in Bangalore

Gabapentin + Nortriptyline Tablet Distributor in Hyderabad

Nerve Pain Treatment Tablet Franchise Opportunity in Jaipur

Chronic Pain Management Tablet Stockist in Mumbai
Gabapentin + Nortriptyline Tablet Export & Manufacturing in Chandigarh

Home/Products /gabapentin-200mg-nortriptyline-10mg-tablet

Gabaxuro NT 200 Tablet

Composition : Gabapentin (200mg) + Nortriptyline (10mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Gabaxuro NT 200 Tablet contains Gabapentin 200mg + Nortriptyline 10mg, a combination therapy for effective neuropathic pain management. Gabapentin acts on nerve signaling to reduce pain transmission, while Nortriptyline modulates neurotransmitters, enhancing pain relief in chronic nerve conditions.

This dual-action formulation is widely used in the management of diabetic neuropathy, post-herpetic neuralgia, and other peripheral neuropathies. Its synergistic effect provides improved patient comfort and better quality of life by reducing persistent nerve pain.

For distributors and hospital suppliers, Gabaxuro NT 200 Tablet is a high-demand neurology product, routinely prescribed in pain clinics, neurology departments, diabetic care centers, and rehabilitation units. Regular prescription cycles ensure stable market movement and repeated orders.

Adding Gabaxuro NT 200 Tablet to your neurology and pain-management segment strengthens your portfolio and opens opportunities in hospital procurement, pharmacy distribution, institutional supply, export markets, and third-party manufacturing. Its clinical efficacy and prescription frequency make it a commercially valuable addition to any pharmaceutical catalogue.

Read More

About the Product

Gabaxuro NT 200 Tablet contains Gabapentin 200mg + Nortriptyline 10mg, a combination therapy for effective neuropathic pain management. Gabapentin acts on nerve signaling to reduce pain transmission, while Nortriptyline modulates neurotransmitters, enhancing pain relief in chronic nerve conditions.

This dual-action formulation is widely used in the management of diabetic neuropathy, post-herpetic neuralgia, and other peripheral neuropathies. Its synergistic effect provides improved patient comfort and better quality of life by reducing persistent nerve pain.

For distributors and hospital suppliers, Gabaxuro NT 200 Tablet is a high-demand neurology product, routinely prescribed in pain clinics, neurology departments, diabetic care centers, and rehabilitation units. Regular prescription cycles ensure stable market movement and repeated orders.

Adding Gabaxuro NT 200 Tablet to your neurology and pain-management segment strengthens your portfolio and opens opportunities in hospital procurement, pharmacy distribution, institutional supply, export markets, and third-party manufacturing. Its clinical efficacy and prescription frequency make it a commercially valuable addition to any pharmaceutical catalogue.

Some patients may experience dizziness, drowsiness, fatigue, dry mouth, constipation, or mild gastrointestinal discomfort. Rarely, allergic reactions, changes in mood, or cardiac arrhythmias may occur.

Gabaxuro NT 200 Tablet is indicated for the treatment of neuropathic pain associated with diabetic neuropathy, post-herpetic neuralgia, or other chronic nerve pain conditions, improving patient comfort and quality of life.

Use strictly under medical supervision. Do not discontinue abruptly. Caution is advised in elderly patients, those with heart conditions, or patients with kidney or liver impairment. Follow the prescribed dosage carefully.

Store Gabaxuro NT 200 Tablet in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation